Treatment of psychogenic polydipsia with pindolol.
Gibson
Carri-Ann M
CA
Stewart
Jonathan T
JT
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D004327:Drinking Behavior / Q000187:drug effects; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D010869:Pindolol / Q000494:pharmacology / Q000627:therapeutic use*; D011433:Propranolol / Q000009:adverse effects / Q000627:therapeutic use; D011602:Psychophysiologic Disorders / Q000150:complications / Q000188:drug therapy*; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy
D000319:Adrenergic beta-Antagonists; D014150:Antipsychotic Agents; D011433:Propranolol; D010869:Pindolol